Chemotherapy with si-RNA and Anti-Cancer Drugs

Kamaljeet Kaur, Goutam Rath, Saket Chandra, Ranjit Singh, Amit Kumar Goyal

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


BACKGROUND: To treat cancer, chemotherapy is a key therapeutic approach which is associated with several limitations. This chemotherapeutical agent exhibits multi drug resistance coupled with undesirable side effects. This multidrug resistance is exhibited by tumor cell due to actuation of drug out flow mechanism, programmed cell death and protection mechanisms etc. One of the therapeutic approaches to cure cancer is RNA interference (RNAi). Small interfering RNA (si-RNA) is considered as a major therapeutic tool used to control expression of a particular gene. It is a well known fact that intake of more drugs can lead to cancer chemo resistance, thus siRNA based therapeutic approach is under scrutiny to cure cancer.
Original languageEnglish (US)
Pages (from-to)300-311
Number of pages12
JournalCurrent Drug Delivery
Issue number3
StatePublished - Jan 1 2018
Externally publishedYes

Bibliographical note

Generated from Scopus record by KAUST IRTS on 2023-10-12


Dive into the research topics of 'Chemotherapy with si-RNA and Anti-Cancer Drugs'. Together they form a unique fingerprint.

Cite this